tiprankstipranks
Trending News
More News >
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market

Pharmarise Holdings Corp. (2796) Income Statement

Compare
0 Followers

Pharmarise Holdings Corp. Income Statement

Last quarter (Q1 2025), Pharmarise Holdings Corp.'s total revenue was ¥16.75B, an increase of 9.99% from the same quarter last year. In Q1, Pharmarise Holdings Corp.'s net income was ¥-18.00M. See Pharmarise Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 63.51B¥ 54.47B¥ 52.03B¥ 51.61B¥ 52.32B
Gross Profit
¥ 8.96B¥ 8.45B¥ 8.13B¥ 8.12B¥ 8.07B
Operating Expenses
¥ 8.67B¥ 7.53B¥ 6.70B¥ 6.60B¥ 6.82B
Depreciation and Amortization
¥ 1.49B¥ 1.17B¥ 1.22B¥ 1.31B¥ 1.34B
EBITDA
¥ 1.68B¥ 1.38B¥ 2.33B¥ 2.69B¥ 2.62B
Operating Income
¥ 293.00M¥ 916.00M¥ 1.44B¥ 1.52B¥ 1.25B
Other Income/Expenses
¥ -285.00M¥ -773.00M¥ -389.00M¥ -199.00M¥ -44.00M
Pretax Income
¥ 8.00M¥ 143.00M¥ 1.05B¥ 1.32B¥ 1.20B
Net Income
¥ -367.00M¥ -351.00M¥ 333.00M¥ 447.00M¥ 426.00M
Per Share Metrics
Basic EPS
¥ -32.42¥ -33.35¥ 35.42¥ 47.90¥ 45.78
Diluted EPS
¥ -32.42¥ -33.35¥ 26.86¥ 36.22¥ 34.59
Weighted Average Shares Outstanding
11.32M 10.52M 9.40M 9.33M 9.31M
Weighted Average Shares Outstanding (Diluted)
11.32M 10.52M 12.47M 12.40M 12.37M
Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History